TITLE

COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus

AUTHOR(S)
Kreiss, C.; Birder, L.A.; Kiss, S.; VanBibber, M.M.; Bauer, A.J.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003, Vol. 52 Issue 4, p527
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Cyclooxygenase 2 (COX-2) and prostaglandins (PGs) participate in the pathogenesis of inflammatory postoperative ileus. We sought to determine whether the emerging neuronal modulator COX-2 plays a significant role in primary afferent activation during postoperative ileus using spinal Fos expression as a marker. Methods: Rats, and COX-2[sup +/+] and COX-2[sup -/-] mice underwent simple intestinal manipulation. The effect of intestinal manipulation on Fos immunoreactivity (IR) in the L[sub 5]-S[sub 1] spinal cord, in situ circumference, and postoperative leucocytic infiltrate of the intestinal muscularis was measured. Postoperative PGE[sub 2] production was measured in peritoneal lavage fluid. The dependence of these parameters on COX-2 was studied in pharmacological (DFU, Merck- Frosst, selective COX-2 inhibitor) and genetic (COX-2[sup -/-] mice) models. Results: Postoperative Fos IR increased 3.7-fold in rats and 2.2-fold in mice. Both muscularis leucocytic infiltrate and the circumference of the muscularis increased significantly in rats and COX-2[sup +/+] mice postoperatively, indicating dilating ileus. Surgical manipulation markedly increased PGE[sub 2] levels in the peritoneal cavity. DFU pretreatment and the genetic absence of COX-2[sup -/-] prevented dilating ileus, and leucocytic infiltrate was diminished by 40% with DFU and by 54% in COX-2[sup -/-] mice. DFU reversed postsurgical intra- abdominal PGE[sub 2] levels to normal. Fos IR after intestinal manipulation was attenuated by approximately 50% in DFU treated rats and in COX-2[sup -/-] mice. Conclusions: Postoperatively, small bowel manipulation causes a significant and prolonged increase in spinal Fos expression, suggesting prolonged primary afferent activation. COX-2 plays a key role in this response. This activation of primary afferents may subsequently initiate inhibitory motor reflexes to the gut, contributing to postoperative ileus.
ACCESSION #
9704747

 

Related Articles

  • Abdominal Cocoon: An Unusual Cause of Subacute Intestinal Obstruction. Shah, Md.; Gedam, B.; Sonarkar, R.; Gopinath, K. // Indian Journal of Surgery;Jun2013 Supplement, Vol. 75, p391 

    We report an unusual cause of subacute intestinal obstruction in a young adolescent girl, which is a nontubercular abdominal cocoon. Barium meal follow-through revealed 'cauliflower'-like appearance of small bowel. The patient underwent an exploratory laparotomy showing thick fibrous-like...

  • LAPAROSCOPY IN THE DIAGNOSIS AND TREATMENT ACUTE INTESTINAL OBSTRUCTION. Abdulayev, Magomed A.; Avdeev, Alexey M.; Abdukhalimov, Karim S.; Artukhov, Sergey V.; Ezzeddin, Ayeb // Vestnik Sankt-Peterburgskogo Universiteta, Seriia 11: Medicina;2015, Issue 1, p10 

    An analysis of case histories of 67 patients aged 18 to 85 years, operated in the Alexander hospital for acute intestinal obstruction from 2006 to 2013 using laparoscopy, was performed. 40 (59,7%) patients were operated on for adhesive acute intestinal obstruction laparoscopically. 16 (23,8%) of...

  • Foreword. Huskisson, Edward C. // Inflammopharmacology;2002, Vol. 10 Issue 3, p157 

    Explains that the development of COX-2 inhibitors should cause doctors to abandon old drugs. Illustration on the effectiveness of using COX-2 inhibitors together with older drugs to relieve patients of suffering; Information on NSAIDS and COX-1 inhibitors.

  • Newly Identified RNA Binding Protein May Assist in Cancer Cell Destruction. Holland-Moritz, Pam // Drug Discovery & Development;May2003, Vol. 6 Issue 5, p22 

    Reports on Washington University School of Medicine researchers' identification of a protein that can help explain one the peculiarities of COX-2. Description of the RNA-binding protein called CUGBP2; Ability to inhibit the translation of the COX-2 protein which halts prostaglandin synthesis.

  • EXPRESSION OF GLUCOCORTICOID RECEPTORS AND CYCLOOXYGENASE-2 IN NASAL POLYPS FROM NONALLERGENIC PATIENTS. Byung-heon Lee; Chang-bae Yun; Jang, Tae-jung // Annals of Otology, Rhinology & Laryngology;Jan2002, Vol. 111 Issue 1, p61 

    Examines the presence of glucocorticoid receptors (GRs) and cyclooxygenase-2 (COX-2) in the nasal polyps of nonallegic patients. Presence of COX-2 in the cytoplasm of surface mucosa; Association of GR labelling to the cytoplasm and nucleus of surface mucosa; Treatment suggested.

  • Gastrointestinal Safety of Selective COX-2 Inhibitors. Hawkey, C.J.; Skelly, M.M. // Current Pharmaceutical Design;Jun2002, Vol. 8 Issue 12, p1077 

    It appears that selective Cox-2 inhibitors do not affect the gastro duodenal mucosa whilst having antiinflammatory and analgesic efficacy similar to non-selective NSAIDs. Two broad categories of drugs are Cox-2 selective: coxibs and a number of pre-existing NSAIDs retrospectively found to have...

  • Comparative Analgesia, Cardiovascular and Renal Effects of Celecoxib, Rofecoxib and Acetaminophen (Paracetamol). Graham, Garry G.; Graham, Robert I.; Day, Richard O. // Current Pharmaceutical Design;Jun2002, Vol. 8 Issue 12, p1063 

    Comparisons are made between the specific COX-2 inhibitors, celecoxib and rofecoxib, and acetaminophen. The specific COX-2 inhibitors are a significant advance in therapy because their antiinflammatory, analgesic and antipyretic activities are associated with a high degree of gastrointestinal...

  • Preface. Brooks, Peter M. // Current Pharmaceutical Design;Jun2002, Vol. 8 Issue 12, p1 

    Introduces the June 2002 issue of 'Current Pharmaceutical Design,' which reviews some of the issues relating to the area of cyclooxygenase (Cox)-2 specificity and major gastrointestinal outcomes trials that have been published on the Cox specific inhibitors. Role of Cox-1 and Cox-2 in the...

  • Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition. de Leval, Xavier; Delarge, Jacques; Somers, Fabian; de Tullio, Pascal; Henrotin, Yves; Pirotte, Bernard; Dogne, Jean-Michel // Current Medicinal Chemistry;Oct2000, Vol. 7 Issue 10, p1041 

    Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physio- logical processes but also in pathological conditions such as inflammation. Since ten years now, it is well known that this enzyme exists under two forms: a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics